DEN170073 is an FDA 510(k) submission (not cleared) for the ContaCT. Classified as Radiological Computer-assisted Triage And Notification Software (product code QAS), Class II - Special Controls.
Submitted by Viz.Al, Inc. (San Francisco, US). The FDA issued a Not Cleared (DENG) decision on February 13, 2018 after a review of 137 days.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2080 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway requires demonstration of substantial equivalence to a legally marketed predicate device - a standard the FDA determined was not met in this submission.
Device pattern: Incremental AI imaging tool. Elevated predicate reliance profile. This submission did not achieve clearance, indicating the FDA determined the device lacked sufficient predicate equivalence under the Radiology review framework.